The VEGFB Gene Variants and the Effectiveness of Platelet-Rich Plasma Treatment of Lateral Elbow Tendinopathy: A Prospective Cohort Study with a Two-Year Follow-Up
Alicja Jarosz, Tomasz Nowak, Karol Szyluk, Anna Balcerzyk-Matić, Tomasz Iwanicki, Joanna Iwanicka, Marcin Kalita, Katarzyna Gawron, Wojciech Kania, Paweł Niemiec · 2024
Read The VEGFB Gene Variants and the Effectiveness of Platelet-Rich Plasma Treatment of Lateral Elbow Tendinopathy: A Prospective Cohort Study with a Two-Year Follow-Up by Alicja Jarosz, Tomasz Nowak, Karol Szyluk, Anna Balcerzyk-Matić, Tomasz Iwanicki, Joanna Iwanicka, Marcin Kalita, Katarzyna Gawron, Wojciech Kania, Paweł Niemiec (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11642232.txt.
Description
Alicja Jarosz and co-authors report a cohort study, published in 2024, asking whether genes shape who benefits from a common elbow treatment. Lateral elbow tendinopathy, often called tennis elbow, is treated with platelet-rich plasma drawn from the patient's own blood, yet results vary. The team focused on variants of a gene called VEGFB, which supports blood vessels and muscle.
More than one hundred patients, covering one hundred and thirty-two elbows, were followed for two years with pain and function scores checked at set visits. Patients carrying certain paired variants reported better relief early in treatment than others. The authors suggest gene testing could one day help predict who gains most from plasma therapy and who should try another route sooner.
Catalog record
| CREATOR | Alicja Jarosz, Tomasz Nowak, Karol Szyluk, Anna Balcerzyk-Matić, Tomasz Iwanicki, Joanna Iwanicka, Marcin Kalita, Katarzyna Gawron, Wojciech Kania, Paweł Niemiec |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |